RESUMO
Muscarinic acetylcholine receptors exist as five subtypes that are widely distributed throughout the body. Conventional pharmacological agents are not highly selective for particular subtypes, making investigations on the functional significance of the subtypes difficult. Recent findings indicate that mamba snake venoms contain several small proteins ('muscarinic toxins') that are highly specific for muscarinic receptors, and are discussed in this review by Diana Jerusalinsky and Alan Harvey. Some of these toxins act selectively and irreversibly on individual subtypes of receptor, and some are antagonists, while others activate muscarinic receptors. The toxins should be useful tools in studies of the functions of individual receptor subtypes, and comparisons of their three-dimensional structures should give clues about how selective binding to muscarinic receptor subtypes can be obtained.
Assuntos
Venenos Elapídicos/química , Proteínas/química , Receptores Muscarínicos/química , Toxinas Biológicas/química , Sequência de Aminoácidos , Animais , Dados de Sequência MolecularRESUMO
Herpes simplex virus-derived amplicon vectors simultaneously expressing the open reading frame encoding NR1 subunit of the NMDA receptor, either in sense or antisense orientation, as well as the open reading frame encoding the green fluorescent protein (GFP), as distinct transcription units, were constructed. Vector expression in cells was demonstrated by GFP-fluorescence, immunofluorescence, Western blots and RT-PCR. The vectors were inoculated into the dorsal hippocampus of adult male rats, which were then trained for habituation to an open field and for inhibitory avoidance to a foot-shock. Those animals injected with vectors expressing NR1 protein showed habituation to a new environment, and achieved the criteria for a step-down inhibitory avoidance to a foot-shock. In contrast, animals injected with vectors carrying the NR1 open reading frame in antisense position, showed neither habituation nor appropriate performance in the inhibitory avoidance task. There was no evidence for motor impairment or motivational disturbance, since all the animals exhibit similar behavior and performance in the training sessions. Hence, the impaired performance might be due to either amnesia or disability to record events. Transgene expression in brain, as revealed by GFP fluorescence, was mainly observed in pyramidal cells of CA1, but also in CA3. Therefore, our results strongly support the participation of hippocampal NR1 subunit in habituation to a new environment, but also in recording events for the inhibitory avoidance task. Hence, amplicon vectors appear to be useful tools to modify endogenous gene expression at a defined period, in restricted brain regions, and should allow investigating in vivo functions of genes.
Assuntos
Comportamento Animal/fisiologia , Técnicas de Transferência de Genes , Vetores Genéticos , Herpesvirus Humano 1/genética , Hipocampo/virologia , Oligonucleotídeos Antissenso/genética , Receptores de N-Metil-D-Aspartato/fisiologia , Animais , Linhagem Celular , Cricetinae , Expressão Gênica , Haplorrinos , Masculino , Aprendizagem em Labirinto/fisiologia , Plasmídeos , Ratos , Ratos Wistar , Receptores de N-Metil-D-Aspartato/genética , TransgenesRESUMO
In rats, three days after unilateral lesion of magnocellular basal forebrain nuclei, binding of L-[3H]-quinuclidinyl benzilate, and acetylcholinesterase activity decreased significantly in the ipsilateral and, to a lesser extent, in the contralateral cerebral cortex. This result suggests the existence of presynaptic muscarinic receptors in the cortical projections of these nuclei. After 14 days, the binding increased on both sides while the level of acetylcholinesterase activity remained low. These findings suggest that deafferentation causes ultimately an increase in postsynaptic receptors.
Assuntos
Encéfalo/fisiologia , Córtex Cerebral/fisiologia , Receptores Muscarínicos/fisiologia , Acetilcolinesterase/metabolismo , Animais , Masculino , Quinuclidinil Benzilato , Ratos , Ratos EndogâmicosRESUMO
Rats, submitted to forced swimming for a period of 15 min (stress), were killed immediately, 60 min or 24 h thereafter. There was an initial decrease in [3H]quinuclidinyl benzilate specific binding in membranes of cerebral cortex (-27%) that returned to normal levels after 60 min. In basal ganglia (striatum and globus pallidus) there was a significant decrease (-14%) in Bmax after 60 min that recovered at 24 h. In cerebellum, an increase in [3H]quinuclidinyl benzilate binding occurred at 60 min (+41%) which was reversed at 24 h. In all cases there were no changes in affinity. These results are discussed in relation to the possible mechanisms that could be involved in the rapid, reversible and selective changes of cholinergic muscarinic receptors in response to acute stress.
Assuntos
Encéfalo/metabolismo , Receptores Muscarínicos/metabolismo , Estresse Fisiológico/metabolismo , Doença Aguda , Animais , Gânglios da Base/metabolismo , Cerebelo/metabolismo , Córtex Cerebral/metabolismo , Feminino , Hipocampo/metabolismo , Masculino , Quinuclidinil Benzilato/metabolismo , Ratos , Ratos EndogâmicosRESUMO
Two new polypeptides were isolated and purified from the venom of the snake Dendroaspis angusticeps, which also contains other neuroactive peptides such as Dendrotoxins and Fasciculins. The amino acid composition of the peptides was determined and the first 10 amino acids from the MTX2 N-terminal fragment were sequenced. The so-called muscarinic toxins (MTX1 and MTX2) have been shown to inhibit the specific binding of [3H]QNB (0.15 nM), [3H]PZ (2.5 nM) and [3H]oxoM (2 nM) to bovine cerebral cortex membranes by 60, 88 and 82% respectively. In contrast, they caused only a 30% blockade of the [3H]QNB specific binding to similar membrane preparations from the brainstem. The Hill number for the [3H]PZ binding inhibition by the putative muscarinic toxin MTX2 was 0.95 suggesting homogeneity in the behaviour of the sites involved. The data from [3H]oxoM binding gave a Hill number of 0.83. The decreases in the specific binding involved increases in KD for the three different ligands (8-fold for [3H]QNB, 4-fold for [3H]PZ and 3.5-fold for [3H]oxoM) without significant changes in Bmax, except for a slight decrease in the [3H]oxoM binding sites (-19%); such results suggest that there may be a competitive inhibition between the MTXs and these ligands. The Ki for MTX2/[3H]PZ was 22.58 +/- 3.52 nM; for MTX2/[3H]oxoM, 144.9 +/- 21.07 nM and for MTX2/[3H]QNB, 134.98 +/- 18.35 nM. The labelling of MTX2 with 125I allowed direct demonstration of specific and saturable binding to bovine cerebral cortex synaptosomal membranes. In conclusion, the results reported in this study strongly support the hypotheses that the two polypeptides isolated from D. angusticeps venom selectively inhibit specific ligand binding to central muscarinic receptors, in a competitive manner at least for the antagonist [3H]PZ and that the MTX2 specifically binds to a central site that is suggested to be a muscarinic receptor of the M1 subtype.
Assuntos
Venenos Elapídicos/farmacologia , Antagonistas Muscarínicos , Sinaptossomos/metabolismo , Aminoácidos/análise , Animais , Tronco Encefálico/metabolismo , Bovinos , Membrana Celular/metabolismo , Córtex Cerebral/metabolismo , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Cromatografia por Troca Iônica , Venenos Elapídicos/isolamento & purificação , Cinética , Neurotoxinas/isolamento & purificação , Neurotoxinas/farmacologia , Quinuclidinil Benzilato/metabolismo , Ensaio Radioligante , Ratos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismoRESUMO
The selectivity of the muscarinic toxin MT3 from green mamba snake venom was corroborated by inhibition of the binding of [3H]NMS, a classical muscarinic radioligand, to native and cloned muscarinic receptors, showing 214-fold higher affinity for m4 than for m1 subtype, without significant binding to the others. The highest concentrations of MT3 sites (putative m4 receptors) in the rat brain were found in striatum and olfactory tubercle, intermediate concentration in dentate gyrus and CA1, and lower but still conspicuous levels in CA3 and frontal cortex. MT3 caused retrograde amnesia of an inhibitory avoidance task, when injected into the dorsal hippocampus of rats after training, suggesting a positive role of these MT3 sensitive sites, which are probably m4 muscarinic receptors, in memory consolidation of this task.
Assuntos
Encéfalo/metabolismo , Venenos Elapídicos/toxicidade , Memória/efeitos dos fármacos , Peptídeos/toxicidade , Receptores Muscarínicos/efeitos dos fármacos , Animais , Autorradiografia , Ligação Competitiva , Peptídeos e Proteínas de Sinalização Intercelular , Cinética , N-Metilescopolamina/metabolismo , Neurotoxinas/toxicidade , Ensaio Radioligante , Ratos , Ratos Wistar , Receptor Muscarínico M4 , Receptores Muscarínicos/metabolismo , TrítioRESUMO
Chicks of 1-8 days after hatching were submitted to unilateral visual deprivation and, in both optic lobes, muscarinic receptors, labeled with L-[3H]quinuclidinyl benzylate [( 3H]L-QNB) and acetylcholinesterase (AChE) were assayed. Between 1 and 6 days the number of [3H]L-QNB binding sites was lower in the contralateral optic lobe; the AChE underwent a drastic reduction (-42% at 2 days); later on the differences became not significant. The pre- and postsynaptic localization of the two cholinergic markers and the possible influence of light on axonal transport are discussed.
Assuntos
Acetilcolinesterase/metabolismo , Receptores Muscarínicos/metabolismo , Privação Sensorial/fisiologia , Visão Ocular/fisiologia , Vias Visuais/metabolismo , Animais , Transporte Axonal , Quinuclidinil Benzilato/metabolismo , Fatores de TempoRESUMO
Several lines of evidence indicate that protein kinase C (PKC) participates in long-term potentiation (LTP) and in certain forms of learning. Here we describe a rapid, specific and time-dependent increase in [3H]phorbol-12,13-dibutyrate ([3H]PDBu) binding to membrane-associated PKC in selected brain regions of rats submitted to an inhibitory avoidance task. A quantitative film autoradiographic method was used to determine the amount and distribution of membrane-bound PKC in rats sacrificed at various time intervals after training. At 0, 30 and 120 min following training there was a prominent increase (up to 200%) in the binding of [3H]PDBu throughout the hippocampus relative to naive, shocked or habituated control groups. No significant changes in [3H]PDBu binding in any brain region were found at 180 min after training. Similar training-specific increments in the binding of [3H]PDBu were observed in the frontal, parietal and entorhinal cerebral cortices, amygdala and cerebellum. The maximal effect was seen at 30 min in the CA2 region of the hippocampus (+200%) and at 30 and 120 min after training in the amygdala (+170%) in comparison to naive control values. No alterations in [3H]PDBu binding were found in the other brain regions studied. The present findings, together with previous data reporting a similar temporal course in the effects of intrahippocampal or intraamygdala infusion of specific PKC inhibitors on memory, suggest that PKC activation plays a role in the acquisition and consolidation of an inhibitory avoidance learning.
Assuntos
Aprendizagem da Esquiva/fisiologia , Encéfalo/enzimologia , Potenciação de Longa Duração , Dibutirato de 12,13-Forbol/metabolismo , Proteína Quinase C/metabolismo , Análise de Variância , Animais , Autorradiografia , Estudos de Avaliação como Assunto , Hipocampo/metabolismo , Masculino , Ensaio Radioligante , Ratos , Ratos Wistar , Fatores de Tempo , TrítioRESUMO
Fasciculin 2 (FAS) an anticholinesterase peptide isolated from the venom of the Green mamba (Dendroaspis angusticeps) was injected into the right striatum of albino rats (1.5 micrograms total amount). The inhibition of acetylcholinesterase (AChE) activity was 86 and 60% 24 h and 7 days after FAS injection, respectively. The treatment with apomorphine (APO) (2 mg/kg s.c.) 24 h after FAS provoked a moderate circling towards the lesioned side that was reverted by atropine (30 mg/kg i.p.). The same dose of APO 7 days after FAS, provoked an inconstant contralateral circling. Neither dopamine nor serotonin nor their metabolites were significantly affected 24 h or 7 days after FAS injection. Radioligand binding assays of dopamine, muscarinic and benzodiazepine receptors only showed a decrease of the density of the muscarinic ones 7 days after FAS. These results are interpreted as showing that the changes provoked by FAS would be compensated but the system would remain in an unsteady state only demonstrable after pharmacological challenge. The chronic down-regulation of muscarinic receptors would compensate the increased cholinergic activity and would therefore block its behavioral expression.
Assuntos
Acetilcolinesterase/metabolismo , Fibras Colinérgicas/fisiologia , Corpo Estriado/enzimologia , Venenos Elapídicos/farmacologia , Comportamento Estereotipado/efeitos dos fármacos , Animais , Fibras Colinérgicas/efeitos dos fármacos , Fibras Colinérgicas/enzimologia , Inibidores da Colinesterase/farmacologia , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/fisiologia , Feminino , Masculino , Ratos , Ratos Endogâmicos , Comportamento Estereotipado/fisiologiaRESUMO
Bilateral intraventricular injections of 0.5 microgram of kainic acid were used to selectively destroy CA3 hippocampal pyramidal neurons, in an effort to clarify the possible localization of muscarinic cholinergic receptors in the rat hippocampal formation. Thirty days after treatment, there was 43% decrease in the total number of [3H]L-QNB binding sites per hippocampus, with no change in affinity. Histological examination confirmed the selective loss of pyramidal neurons in subareas CA3a-b while other regions of the hippocampal formation were spared. The unilateral transection of the fimbria-fornix, done 14 days after kainic acid, produced a further reduction in binding in relation to control hippocampi (-57%). The results demonstrate that in the pyramidal cells of CA3 there is a high concentration of postsynaptic muscarinic receptors. However, the slight further decrease, found after fimbria-fornix transection, suggests the possible existence of a small population of presynaptic receptors that, hitherto, had only been demonstrated indirectly by physiological methods.
Assuntos
Hipocampo/análise , Ácido Caínico/farmacologia , Pirrolidinas/farmacologia , Receptores Colinérgicos/análise , Receptores Muscarínicos/análise , Animais , Masculino , Proteínas do Tecido Nervoso/análise , Vias Neurais/anatomia & histologia , Quinuclidinil Benzilato/metabolismo , Ratos , Ratos EndogâmicosRESUMO
The effects of habituation and inhibitory avoidance training on the rat brain regional levels of benzodiazepine (BZD)-like molecules and on central type BZD binding sites were examined. BZD-like immunoreactivity was decreased by 26-50% in the amygdala, cerebral cortex and septum of rats sacrificed immediately after stepping-down from the platform of an inhibitory avoidance apparatus (non-trained group) as compared to naive controls. Rats submitted to a second step-down session 20 h later (habituated group) have significantly lower BZD-like immunoreactivity in the septum (-60%) as compared to non-trained animals. Rats exposed to an inhibitory avoidance training, i.e. stepping-down and receiving a footshock (trained group), showed a significant reduction in the content of BZD-like molecules in cerebral cortex (-44%), amygdala (-68%), septum (-80%) and hippocampus (-82%) as compared to non-trained rats. In addition, the density of central type BZD binding sites was slightly increased in the hippocampus and septum of trained rats. No changes were observed in the apparent dissociation constant. No changes were observed in parallel measurements of [3H]-L-quinuclidinyl benzylate binding constants at cholinergic muscarinic binding sites. The immediate posttraining intrahippocampal bilateral injection of the central type BZD receptor antagonist flumazenil (10 nmol/hippocampus), enhanced the retention of habituation but not when injected in the amygdala or septum. In contrast, retention of the inhibitory avoidance task was significantly increased by flumazenil administered bilaterally into any of the 3 brain structures.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Aprendizagem da Esquiva , Benzodiazepinas/metabolismo , Química Encefálica , Encéfalo/fisiologia , Flumazenil/farmacologia , Habituação Psicofisiológica , Animais , Aprendizagem da Esquiva/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Flumazenil/administração & dosagem , Flunitrazepam/metabolismo , Habituação Psicofisiológica/efeitos dos fármacos , Masculino , Microinjeções , Quinuclidinil Benzilato/metabolismo , Ratos , Ratos Endogâmicos , Receptores de GABA-A/efeitos dos fármacos , Receptores de GABA-A/metabolismo , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Valores de Referência , Comportamento Estereotipado/efeitos dos fármacosRESUMO
The effects of the peptide fasciculin (FAS), a potent inhibitor of acetylcholinesterase (AChE) have been examined, following unilateral microinfusion, on tissue levels of monoamines in the rat substantia nigra and concomitant circling behaviour. Although FAS inhibited 87% of total AChE, the levels of dopamine and its metabolites remained unchanged. Furthermore, the treatment induced modest contraversive rotation which was markedly enhanced in the presence of a systemic challenge with apomorphine. This behavioural effect of FAS was partially reversed by systemically administered atropine. Any possible interaction of FAS with nigral dopamine systems was further investigated by testing the peptide in animals that five days earlier had undergone a 6-hydroxydopamine (6-OHDA) lesion of the SN such that dopamine and AChE were significantly but not completely reduced. In a majority of these animals, FAS treatment caused a reversal of the lesion induced ipsiversive rotation, ie restored contraversive rotation. It is concluded that in the SN, FAS can have biochemical and behavioural actions independent of local dopamine systems and linked to cholinergic transmission. In addition, treatment with FAS in the substantia nigra also reveals the possible existence of at least two distinct pools of AChE with, respectively, non-cholinergic and cholinergic actions.
Assuntos
Acetilcolinesterase/metabolismo , Aminas Biogênicas/metabolismo , Inibidores da Colinesterase/farmacologia , Venenos Elapídicos/farmacologia , Atividade Motora/efeitos dos fármacos , Substância Negra/fisiologia , Ácido 3,4-Di-Hidroxifenilacético/metabolismo , Animais , Apomorfina/farmacologia , Membrana Celular/enzimologia , Dopamina/metabolismo , Lateralidade Funcional , Ácido Homovanílico/metabolismo , Ácido Hidroxi-Indolacético/metabolismo , Masculino , Norepinefrina/metabolismo , Oxidopamina , Ratos , Ratos Endogâmicos , Receptores Muscarínicos/efeitos dos fármacos , Receptores Muscarínicos/metabolismo , Rotação , Serotonina/metabolismo , Substância Negra/efeitos dos fármacos , Substância Negra/enzimologiaRESUMO
The effect of chronic administration of haloperidol on alpha 1-, alpha 2-, and beta-adrenoceptors, cholinergic muscarinic, GABAA and benzodiazepine receptors in the cerebral cortex of the rat was investigated. Doses of 0.3 and 2 mg/kg of haloperidol during 7 days increased markedly the density of alpha 1-adrenoceptors without changes in affinity. The alpha 2- and beta-adrenoceptors were not modified after neuroleptic administration. The number of muscarinic receptors were also increased after haloperidol treatment (2 mg/kg/day). However, the GABAA and benzodiazepine binding sites remained unchanged. In the brainstem an increment in the alpha 1-, but not the beta-adrenoceptors was observed. The well known increase in the dopamine receptors in the striatum was confirmed. These observations demonstrate a multireceptor effect of haloperidol in the cerebral cortex.
Assuntos
Córtex Cerebral/efeitos dos fármacos , Haloperidol/farmacologia , Receptores Adrenérgicos alfa/efeitos dos fármacos , Receptores Muscarínicos/efeitos dos fármacos , Animais , Tronco Encefálico/efeitos dos fármacos , Tronco Encefálico/metabolismo , Córtex Cerebral/metabolismo , Haloperidol/administração & dosagem , Cinética , Masculino , Ratos , Ratos Endogâmicos , Receptores Adrenérgicos alfa/classificação , Receptores Adrenérgicos alfa/metabolismo , Receptores de GABA-A/efeitos dos fármacos , Receptores de GABA-A/metabolismo , Receptores Muscarínicos/metabolismo , Frações Subcelulares/metabolismoRESUMO
A peptide, muscarinic toxin 2 (MTX2), isolated from Dendroaspis angusticeps venom was previously shown to displace the specific binding of [3H]pirenzepine, a muscarinic M1 receptor ligand, from rat brain synaptosomal membranes. We have tested MTX2 for muscarinic agonist or antagonist actions in an inhibitory avoidance task in rats. Infusion of the muscarinic receptor antagonist scopolamine into the hippocampus of rats immediately after the training period produced amnesia, whereas the muscarinic agonist oxotremorine increased retention. When MTX2 was injected into the hippocampus of rats after the inhibitory avoidance task, it caused memory facilitation, which could be suppressed by the concomitant infusion of scopolamine. Hence, in this test, MTX2 showed muscarinic receptor agonist-like actions, which are probably mediated by the M1 subtype of muscarinic acetylcholine receptors.
Assuntos
Aprendizagem da Esquiva/efeitos dos fármacos , Venenos Elapídicos/farmacologia , Neurotoxinas/farmacologia , Parassimpatomiméticos/farmacologia , Receptores Muscarínicos/efeitos dos fármacos , Animais , Ratos , Ratos Wistar , Proteínas de Répteis , Escopolamina/farmacologiaRESUMO
The venom of some Dendroaspis snakes contains small proteins (7500 mol. wt) that inhibit the binding of radiolabelled muscarinic antagonist to brain synaptomal membranes. There were no peptides described among muscarinic ligands until Adem et al. (Biochim. biophys. Acta 968, 340-345, 1988) reported that muscarinic toxins (MTxs), MTx1 and 2 were able to inhibit 3H-QNB binding to rat brain membranes. Since MTxs inhibit around half of specific binding of 3H-quinuclidinyl benzilate (3H-QNB) and 3H-N-methyl-scopolamine (3H-NMS), which do not discriminate between subtypes of muscarinic receptors, it has been proposed that MTxs might selectively bind to some subtype. MTx1 and 2 from Dendroaspis angusticeps almost completely inhibit the binding of 3H-pirenzepine (3H-PZ), a preferential M1 muscarinic receptor subtype ligand to cerebral cortex synaptosomal membranes. A much higher concentration was needed to inhibit partially 3H-PZ binding to atrial muscarinic receptors. These results support the hypothesis that MTx1 and 2 may be M1 selective muscarinic ligands. Similar activities have been found in Dendroaspis polylepis and D. viridis venoms, but with lower affinities. The Ki obtained from inhibition curves of the binding of 3H-PZ showed that MTx1 has higher affinity for the putative M1 muscarinic receptor subtype, followed by MTx2. DpMTx has lower affinity, while DvMTx seems to have the lowest affinity. All these peptides are devoid of anticholinesterase activity. Dendrotoxin and fasciculin from D. angusticeps venom do not inhibit the binding of muscarinic radioligands to cerebral cortex membranes. The injection of MTxs into dorsal hippocampus of rats immediately after training in an inhibitory avoidance task improves memory consolidation, as does oxotremorine.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Venenos Elapídicos/toxicidade , Agonistas Muscarínicos/toxicidade , Animais , Comportamento Animal/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Córtex Cerebral/metabolismo , Técnicas In Vitro , Cinética , Ligantes , Memória/efeitos dos fármacos , N-Metilescopolamina , Pirenzepina/farmacocinética , Ratos , Ratos Wistar , Receptores Colinérgicos/efeitos dos fármacos , Receptores Colinérgicos/metabolismo , Derivados da Escopolamina/metabolismo , Especificidade da Espécie , Técnicas Estereotáxicas , Sinaptossomos/efeitos dos fármacos , Sinaptossomos/metabolismoRESUMO
Muscarinic toxins MTx1 and MTx2 are 7500 mol. wt polypeptides isolated from the venom of the green mamba snake Dendroaspis angusticeps. Previous competition binding studies indicate that the MTxs may be selective for the M1 subtype of muscarinic acetylcholine receptors. The present work was undertaken in order to clarify the muscarinic subtype specificity and functional effects of MTx1 and MTx2. Binding interactions were determined using 3H-N-methyl scopolamine (NMS) and cloned human muscarinic receptor subtypes m1, m2, m3 and m4. Some preliminary functional studies were performed on rabbit vas deferens preparations, which contain M1 cholinoceptors. MTx1 and MTx2 inhibited 3H-NMS binding to m1 and m3 receptors, with little effect on binding to m2 and m4 receptors. Affinity was higher for m1 receptors: Ki for MTx1 were 48 nM at m1 receptors and 72 nM at m3 receptors, and Ki for MTx2 were 364 nM at m1 and 1.2 microM at m3 receptors. At m1 receptors, about 90% of the binding of MTx1 and MTx2 appears to be irreversible. On rabbit vas deferens preparations, MTx1 and MTx2 at concentrations above 50 nM behaved in a similar way to the relatively selective M1-agonists McN-A-343 and CPCP (4-[N-(chlorophenyl)carbamoyloxy]-4-20-ynyl-trimethylammoniu m iodide) by reducing responses to nerve stimulation. The results confirm that MTx1 and MTx2 bind to m1 receptors rather than to m2 or m4 receptors, but they also reveal a slightly weaker effect at m3 receptors. The interaction at m1 receptors appears to be essentially irreversible, implying that the toxins could be useful tools in studies of the functional role of m1 muscarinic receptors.
Assuntos
Venenos Elapídicos/metabolismo , Neurotoxinas/metabolismo , Receptores Muscarínicos/metabolismo , Animais , Venenos Elapídicos/farmacologia , Masculino , Neurotoxinas/farmacologia , Coelhos , Ensaio Radioligante , Receptores Muscarínicos/genética , Proteínas Recombinantes/metabolismo , Proteínas de RépteisRESUMO
Muscarinic receptors are widely spread throughout the body, and are involved in the regulation of fundamental physiological processes, like the modulation of the heart rate, control of motor systems and modulation of learning and memory. In the central nervous system the cholinergic transmission is mainly mediated by muscarinic receptors; there are five subtypes that are all expressed in the brain of mammals (m1-m5). There are regional differences in their concentrations in the brain and more than one subtype is expressed in the same cell. It has been difficult to study their localization and function in vivo due to the lack of ligands that exclusively act on one subtype of the receptor. We studied the action of the muscarinic toxins MT1, MT2 and MT3, from the venom of the snake Dendroaspis angusticeps, on muscarinic receptors, by using the classical muscarinic radioligand 3H-NMS as reporter of the inhibition of its own binding, to either native or cloned receptors. We have also studied the in vivo effects on memory retention of the injection of the toxins into discrete brain regions. The muscarinic toxins appear to be invaluable tools to study receptor pharmacology, physiology and structure/function relationships. They would enable the design of new, more selective, pharmacological agents.
Assuntos
Receptores Muscarínicos/administração & dosagem , Receptores Muscarínicos/fisiologia , Toxinas Biológicas/farmacologia , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Venenos Elapídicos/administração & dosagem , Venenos Elapídicos/farmacologia , Humanos , Injeções Intraventriculares , Receptores Muscarínicos/metabolismo , Toxinas Biológicas/administração & dosagem , Toxinas Biológicas/metabolismoRESUMO
Toxins are of interest in drug design because the toxins provide three-dimensional templates for creating small molecular mimics with interesting pharmacological properties. Toxins are also useful in drug discovery because they can be used as pharmacological tools to uncover potential therapeutic targets. With their high potency and selectivity, toxins are often more useful in functional experiments than standard pharmacological agents. We have used two groups of neurotoxins, the dendrotoxins and the muscarinic toxins (MTs), to explore the involvement of subtypes of potassium ion channels and muscarinic receptors, respectively, in processes involved in cognition and the changes in neuronal properties with aging. From our current work, quantitative autoradiographic studies with radiolabelled dendrotoxins reveal widespread distribution of binding sites throughout rat brain sections, but few differences exist between young adult and aged rats. However, displacement studies with toxin K, which preferentially binds to the Kv1.1 subtype of cloned potassium channel, show the selective loss of such sites in regions of the hippocampus and septohippocampal pathway with aging. MTs have been tested for effects on performance of rats in memory paradigms. MT2, which activates m1 receptors, improves performance of rats in a step-down inhibitory avoidance test, whereas MT3, which blocks m4 receptors, decreases performance when given into the hippocampus. This is the first clear demonstration of a role for m4 muscarinic receptors in cognition.
Assuntos
Desenho de Fármacos , Toxinas Biológicas/química , Animais , Ligação Competitiva , Venenos Elapídicos/farmacologia , Peptídeos e Proteínas de Sinalização Intercelular , Memória/efeitos dos fármacos , Antagonistas Muscarínicos/farmacologia , Neurônios/efeitos dos fármacos , Neurotoxinas/farmacologia , Peptídeos/farmacologia , Bloqueadores dos Canais de Potássio , Ratos , Receptores Muscarínicos/efeitos dos fármacos , Proteínas de RépteisRESUMO
One of the most interesting recent developments in the pharmacology of muscarinic receptors has been the finding of small proteins in the venoms of mamba snakes that bind with high affinity and selectivity to different subtypes of muscarinic receptors. In the workshop on muscarinic toxins, the practicalities of isolating, characterising and using these toxins as tools in the study of muscarinic receptors were discussed.
Assuntos
Venenos Elapídicos/farmacologia , Receptores Muscarínicos/efeitos dos fármacos , Toxinas Biológicas/farmacologia , Animais , HumanosRESUMO
1. Recent evidence indicates that post-training memory processes are down-regulated by benzodiazepine/GABA-A systems in the amygdala, septum and hippocampus. Habituation and avoidance learning are accompanied by a decrease of benzodiazepine-like immunoreactivity in the three structures, explainable by a release of benzodiazepines. Immediate post-training microinjection of the benzodiazepine antagonist flumazenil into the hippocampus enhances retention of habituation. The post-training administration of flumazenil into any of the three structures enhances retention of avoidance learning. 2. The mode of operation of these systems was studied in detail in the amygdala using avoidance paradigms. The release of endogenous benzodiazepines during and particularly after training enhances sensitivity of local GABA-A receptors to muscimol, activation of the GABA-A receptors opens chloride channels that can be selectively blocked by picrotoxin and by Ro5-4864. Training enhances, and flumazenil reduces, sensitivity of the amygdala to the amnestic effect of locally injected muscimol by a factor of 100. Post-training intra-amygdala administration of picrotoxin or Ro5-4864 enhances retention. 3. These findings suggest that the endogenous benzodiazepine/GABA-A mechanisms that down-regulate memory in the amygdala, septum and hippocampus are activated in response to the anxiety and/or stress associated with each task. Memory lability which occurs in the post-training period and characterizes consolidation would thus be a consequence of the brain's response to anxiety or stress.